SCHEMBL10242830

SCHEMBL10242830

O=C1NCC(c2ccccn2)N1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.44
KMT2A Q03164 3/20 0.44
RAB9A P51151 3/20 0.44
MAPT P10636 2/20 0.44
NPC1 O15118 1/20 0.44
DDB1 Q16531 1/20 0.44
CRBN Q96SW2 1/20 0.44
GSK3B P49841 1/20 0.40
KDM4E B2RXH2 6/20 0.38
PARP16 Q8N5Y8 2/20 0.38
PARP3 Q9Y6F1 2/20 0.38
MEN1 O00255 2/20 0.38
TSHR P16473 2/20 0.38
GFER P55789 1/20 0.38
HSD17B10 Q99714 2/20 0.37
LMNA P02545 2/20 0.37
TP53 P04637 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
HPGD P15428 3/20 0.37
GAA P10253 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20993365 0.86 ALDH1A1 (0.44) ALDH1A1KMT2ARAB9AMAPTNPC1
SCHEMBL20993213 0.86 ALDH1A1 (0.44) ALDH1A1KMT2ARAB9AMAPTNPC1
SCHEMBL18150679 0.74 CRBN (0.58) ALDH1A1KMT2ARAB9AMAPTNPC1
SCHEMBL10041515 0.73 NOS1 (0.49) ALDH1A1KMT2AMAPTKDM4EGFER
SCHEMBL2199447 0.73 NOS1 (0.49) ALDH1A1KMT2AMAPTKDM4EGFER
SCHEMBL1439472 0.72 ALDH1A1 (0.42) ALDH1A1KMT2ARAB9AMAPTNPC1
SCHEMBL1440419 0.72 ALDH1A1 (0.42) ALDH1A1KMT2ARAB9AMAPTNPC1
SCHEMBL23745244 0.71 DDB1 (0.51) ALDH1A1KMT2ARAB9AMAPTNPC1
SCHEMBL2563428 0.71 DDB1 (0.51) ALDH1A1KMT2ARAB9AMAPTNPC1
SCHEMBL16268284 0.71 DDB1 (0.44) ALDH1A1KMT2ARAB9AMAPTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018011160-A1 6,7-DIHYDRO-4H-PYRAZOLO[1,5-A]PYRAZINE COMPOUNDS FOR THE TREATMENT OF INFECTIOUS DISEASES F. HOFFMANN-LA ROCHE AG (CH) 2018-01-18 WO disclosed
EP-1765793-B1 ANACETRAPIB AND OTHER CETP INHIBITPRS MERCK SHARP & DOHME (US) 2012-09-26 EP disclosed
EP-2415759-A1 CETP inhibitors Merck Sharp & Dohme Corporation (US) 2012-02-08 EP disclosed